Targeting C-Met Receptor Tyrosine Kinase by the DNA Aptamer SL1 as a Potential Novel Therapeutic Option for Myeloma
Journal of Cellular and Molecular Medicine - United Kingdom
doi 10.1111/jcmm.13870
Full Text
Open PDFAbstract
Available in full text
Date
October 24, 2018
Authors
Publisher
Wiley